Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
29.1M
-
Number of holders
-
112
-
Total 13F shares, excl. options
-
16.3M
-
Shares change
-
-127K
-
Total reported value, excl. options
-
$851M
-
Value change
-
-$12M
-
Put/Call ratio
-
0.6
-
Number of buys
-
54
-
Number of sells
-
-41
-
Price
-
$52.21
Significant Holders of Krystal Biotech, Inc. - COMMON STOCK (KRYS) as of Q3 2021
142 filings reported holding KRYS - Krystal Biotech, Inc. - COMMON STOCK as of Q3 2021.
Krystal Biotech, Inc. - COMMON STOCK (KRYS) has 112 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16.3M shares
of 29.1M outstanding shares and own 56.05% of the company stock.
Largest 10 shareholders include Redmile Group, LLC (1.98M shares), FMR LLC (1.9M shares), BlackRock Inc. (1.54M shares), LORD, ABBETT & CO. LLC (1.07M shares), VANGUARD GROUP INC (889K shares), CREDIT SUISSE AG/ (772K shares), FRAZIER MANAGEMENT LLC (771K shares), STATE STREET CORP (737K shares), PICTET ASSET MANAGEMENT SA (637K shares), and First Light Asset Management, LLC (633K shares).
This table shows the top 112 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.